Palmer Eric P 4
4 · LifeStance Health Group, Inc. · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
LifeStance (LFST) Director Eric Palmer Receives 17,746 RSUs
What Happened
Eric Palmer, a director of LifeStance Health Group, Inc. (LFST), was granted 17,746 restricted stock units (RSUs) on July 2, 2026. The Form 4 reports the acquisition price as $0.00 (an award/compensation grant). Each RSU represents a contingent right to receive one share of LifeStance common stock if and when the RSUs vest.
Key Details
- Transaction date: July 2, 2026; Form 4 filed July 7, 2026.
- Transaction type/code: Award/Grant (A). Reported acquisition: 17,746 RSUs at $0.00.
- Shares owned after transaction: Not specified in the provided filing.
- Footnote: F1 — the 17,746 items are RSUs; each RSU is a contingent right to one common share upon vesting.
- Timing note: The Form 4 was filed five days after the reported transaction date; Form 4s are generally required within two business days, so investors may want to watch for any related disclosures.
Context
RSU grants are typically part of director or executive compensation and do not represent an open-market purchase or sale. They do not provide immediate shares or proceeds — the units convert to stock only if vesting conditions are met. Such awards are common and should be interpreted as compensation rather than a direct bullish or bearish trading signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-07-02+17,746→ 89,174 total
Footnotes (1)
- [F1]Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.